These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 21922530

  • 1. Hydroxyurea use in patients with sickle cell disease in a Medicaid population.
    Ritho J, Liu H, Hartzema AG, Lottenberg R.
    Am J Hematol; 2011 Oct; 86(10):888-90. PubMed ID: 21922530
    [No Abstract] [Full Text] [Related]

  • 2. Examining the effectiveness of hydroxyurea in people with sickle cell disease.
    Lanzkron S, Haywood C, Fagan PJ, Rand CS.
    J Health Care Poor Underserved; 2010 Feb; 21(1):277-86. PubMed ID: 20173269
    [Abstract] [Full Text] [Related]

  • 3. Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.
    Tripathi A, Jerrell JM, Stallworth JR.
    Pediatr Blood Cancer; 2011 Jan; 56(1):90-4. PubMed ID: 20922765
    [Abstract] [Full Text] [Related]

  • 4. Hydroxyurea for the treatment of sickle cell anemia.
    Platt OS.
    N Engl J Med; 2008 Mar 27; 358(13):1362-9. PubMed ID: 18367739
    [No Abstract] [Full Text] [Related]

  • 5. Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment.
    Makis AC, Hatzimichael EC, Kolios G, Bourantas KL.
    Haematologica; 2004 Mar 27; 89(3):360-1. PubMed ID: 15020278
    [Abstract] [Full Text] [Related]

  • 6. Sickle cell patients find a brand New World.
    Noonan SS.
    N J Med; 1999 Aug 27; 96(8):23-5. PubMed ID: 10457727
    [Abstract] [Full Text] [Related]

  • 7. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P, Barretto de Mello A, Figueiredo MS.
    Am J Hematol; 2005 Mar 27; 78(3):243-4. PubMed ID: 15726590
    [Abstract] [Full Text] [Related]

  • 8. Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.
    Nzouakou R, Bachir D, Lavaud A, Habibi A, Lee K, Lionnet F, Hulin A, Jouault H, Préhu C, Roudot-Thoraval F, Girot R, Galactéros F.
    Acta Haematol; 2011 Mar 27; 125(3):145-52. PubMed ID: 21196716
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyurea for sickle cell anemia.
    Naina HV, Harris S.
    N Engl J Med; 2008 Jul 03; 359(1):98; author reply 98-9. PubMed ID: 18596283
    [No Abstract] [Full Text] [Related]

  • 10. Hydroxyurea and new agents for the treatment of sickle cell disease.
    Rodgers GP.
    Clin Adv Hematol Oncol; 2004 Nov 03; 2(11):713-5. PubMed ID: 16163257
    [No Abstract] [Full Text] [Related]

  • 11. [Evaluation of clinical response by hydroxyurea in 132 patients with major sickle cell anemia].
    Elira Dokekias A, Okandze Elenga JP, Ndinga J, Sanogo I, Sangare A.
    Tunis Med; 2005 Jan 03; 83(1):32-7. PubMed ID: 15881719
    [Abstract] [Full Text] [Related]

  • 12. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Jan 03; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 13. Treatment adherence in patients with sickle cell anemia.
    Drotar D.
    J Pediatr; 2010 Mar 03; 156(3):350-1. PubMed ID: 20056235
    [No Abstract] [Full Text] [Related]

  • 14. Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease.
    Mahadeo KM, Oyeku S, Taragin B, Rajpathak SN, Moody K, Santizo R, Driscoll MC.
    Am J Hematol; 2011 Sep 03; 86(9):806-8. PubMed ID: 21850660
    [No Abstract] [Full Text] [Related]

  • 15. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea.
    Stettler N, McKiernan CM, Melin CQ, Adejoro OO, Walczak NB.
    JAMA; 2015 Apr 28; 313(16):1671-2. PubMed ID: 25919532
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT, de Lucena Angulo I, Vianna Bonini Palma P, Zago MA.
    Haematologica; 2004 Mar 28; 89(3):273-80. PubMed ID: 15020264
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.